A randomized, open-label, multicenter, two arm, phase II study to evaluate treatment compliance, efficacy and safety of an improved deferasirox formulation (granules) in pediatric patients with iron overload Save

Date Added
June 14th, 2016
PRO Number
Pro00055685
Researcher
Sherron Jackson
Keywords
Blood Disorders
Summary

This study is searching for patients ages 2 to 18 years old with iron overload to test a new improved formulation of the drug deferasirox. The study is testing to see if patients will be more compliant with the new formulation of granules and if the formulation will have the same effectiveness and safety responses as the pill formulation. If eligible, subjects will be asked to visit the outpatient clinic 16 times over 48 weeks.

Institution
MUSC
Recruitment Contact
Karen Hawkins
843-792-0560
hawkink@musc.edu

Change_preferences

-- OR --

Create_login